HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phillip Scheinberg Selected Research

thymoglobulin

11/2018Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
11/2017Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.
9/2015Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia.
5/2015Answer to "Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia".
9/2014Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A.
9/2014In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.
5/2014Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.
1/2011Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Phillip Scheinberg Research Topics

Disease

40Aplastic Anemia (Anemia, Hypoplastic)
01/2021 - 06/2006
7Infections
10/2019 - 07/2009
6Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
10/2021 - 07/2006
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2020 - 04/2011
4Pancytopenia
01/2020 - 05/2008
3Cytopenia
12/2020 - 01/2016
3Hemolysis
01/2019 - 07/2006
3Graft vs Host Disease (Graft-Versus-Host Disease)
05/2011 - 06/2006
2Lymphoma (Lymphomas)
11/2021 - 10/2019
2COVID-19
01/2021 - 07/2020
2Thrombocytopenia (Thrombopenia)
12/2020 - 09/2014
2Neutropenia
10/2019 - 01/2012
2Chromosome Aberrations (Chromosome Abnormalities)
03/2014 - 12/2010
2Hematologic Diseases (Blood Diseases)
04/2013 - 10/2006
2Bone Marrow Failure Disorders
08/2012 - 04/2007
2Thrombosis (Thrombus)
07/2010 - 12/2008
2Pure Red-Cell Aplasia
03/2010 - 02/2006
2Neoplasms (Cancer)
03/2009 - 09/2008
1Multiple Myeloma
01/2022
1Hemorrhage
12/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2021
1Fibrosis (Cirrhosis)
12/2020
1Leukopenia
10/2019
1Anemia
01/2019
1Disease Progression
06/2016
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
06/2016
1Muscle Cramp (Cramp)
05/2016
1Cytokine Release Syndrome
09/2014
1Serum Sickness
09/2014
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
09/2014
1Genomic Instability
05/2013
1Aneuploidy (Aneuploid)
08/2012
1monosomy Chromosome 7
08/2012
1Sepsis (Septicemia)
01/2012
1Invasive Candidiasis
01/2012
1Wilms Tumor (Wilm's Tumor)
03/2011

Drug/Important Bio-Agent (IBA)

21Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
11/2018 - 06/2006
17Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2018 - 06/2006
10eltrombopagFDA Link
01/2021 - 07/2012
8thymoglobulinFDA Link
11/2018 - 01/2011
4Thrombopoietin (c-mpl Ligand)IBA
12/2020 - 04/2011
3eculizumabFDA Link
10/2021 - 07/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016 - 05/2014
3Proteins (Proteins, Gene)FDA Link
03/2011 - 07/2006
2fibrin fragment D (D-dimer)IBA
12/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2017
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021 - 07/2010
2tocilizumab (atlizumab)FDA Link
01/2021 - 07/2020
2Thrombopoietin ReceptorsIBA
12/2020 - 01/2017
2Alemtuzumab (Campath)FDA Link
01/2019 - 01/2012
2CytokinesIBA
09/2014 - 04/2011
2LigandsIBA
01/2012 - 04/2011
2Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
07/2010 - 07/2006
2Daclizumab (Zenapax)FDA Link
03/2010 - 02/2006
2AntigensIBA
03/2009 - 09/2008
1Melphalan (Alkeran)FDA LinkGeneric
01/2022
1Chimeric Antigen ReceptorsIBA
11/2021
1Oxygen (Dioxygen)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Ferritins (Ferritin)IBA
01/2021
1Reticulin (Reticular Fiber)IBA
12/2020
1Interleukin-6 (Interleukin 6)IBA
07/2020
1Rituximab (Mabthera)FDA Link
10/2019
1Lenalidomide (CC 5013)FDA Link
10/2019
1Complement System Proteins (Complement)IBA
01/2019
1Hemoglobins (Hemoglobin)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2017
1EnzymesIBA
05/2016
1Danazol (Azol)FDA LinkGeneric
05/2016
1Methotrexate (Mexate)FDA LinkGeneric
01/2016
1fludarabineIBA
09/2014
1AntibodiesIBA
09/2014
1Immunoglobulin M (IgM)IBA
09/2014
1Pharmaceutical PreparationsIBA
03/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2013
1telomerase RNA (bTR)IBA
05/2013
1SurvivinIBA
08/2012
1Cyclin D1IBA
08/2012
1SulfonesIBA
08/2012
1ON 01910IBA
08/2012
1Chemokine ReceptorsIBA
01/2012
1CXC ChemokinesIBA
04/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011
1Epidermal Growth Factor (EGF)IBA
04/2011
1Chemokine CCL11IBA
04/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2011
1CC ChemokinesIBA
04/2011
1CD40 Ligand (CD40L)IBA
04/2011

Therapy/Procedure

18Therapeutics
01/2021 - 01/2009
8Hematopoietic Stem Cell Transplantation
01/2020 - 06/2006
4Stem Cell Transplantation
01/2016 - 06/2006
4Transplantation
01/2012 - 10/2006
2Cell Transplantation
09/2014 - 05/2011
2Aftercare (After-Treatment)
03/2011 - 12/2010
2Drug Therapy (Chemotherapy)
07/2009 - 10/2006
1Artificial Respiration (Mechanical Ventilation)
01/2021
1Erythrocyte Transfusion
01/2019
1Salvage Therapy
05/2014
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2013
1Homologous Transplantation
07/2012